Polymorphisms of leptin receptor (LEPR) may contribute to a common form of obesity and, as a consequence, obesity-related diseases. We evaluated the potential role of genetic variation at the LEPR gene in heart sympathetic activity and other traits related to obesity in Mexican adolescents. Adolescents aged between 12 and 17 years, with steady body weight for the last 3 months were included. We evaluated anthropometric measurements, blood pressure, seric glucose, insulin, leptin levels, heart sympathetic activity (by electrocardiograph monitoring at rest), and the Gln223Arg and Pro1019Pro LEPR polymorphisms in each subject. In total, 103 adolescents (55 obese and 48 nonobese) were included. The group of obese adolescents showed higher sympathetic activity, blood pressure, glucose, insulin, and leptin levels. The genotype frequencies for the two polymorphisms were found to be in Hardy-Weinberg equilibrium. There was no difference in the genotype frequencies for Gln223Arg or Pro1019-Pro polymorphisms between obese and nonobese adolescents. However, there was a higher prevalence of Gln223 allele among subjects with higher insulin levels (0.72 vs 0.57; P ¼ 0.04 for adolescents with insulin levels higher and lower than 100 pmol/l, respectively). According to Gln223Arg polymorphism, those with Gln allele (Gln/Gln and Gln/Arg) had higher heart sympathetic activity, body fat percentage, and leptin levels. To conclude, our results support the hypothesis that Gln223Arg polymorphism of LEPR in Mexican adolescents is associated with haemodynamic and metabolic disturbances related to obesity.
Introduction
In the past two decades, there has been a 2-4-fold increase in childhood obesity in the United States. The current epidemic of childhood obesity can be expected to cause a surge in cardiovascular disease in this generation. 1 In México, Hernández et al 2 reported 24% prevalence of obesity in children and adolescents. Obesity is due to the combined effects of genes, environment, lifestyle, and the interactions of these factors. 3 Studies have identified several critical periods for the development of childhood or adolescent-onset obesity; these include gestation, 4 the period of 'adiposity rebound' (aged 3-6 years), 5 and puberty. 6 Increased rates of comorbidities such as dyslipidaemia, hypertension, and type II diabetes in overweight and obese adolescents indicate that the young are not protected from the metabolic perturbations that accompany excess adipose tissue stores. 7, 8 Leptin (LEP) gene and leptin receptor (LEPR) gene products, respectively, have defined a new biological pathway for the regulation of food intake and energy expenditure. Leptin is released from adipocytes as a signal of body fat stores and acts as a satiety factor with its receptor located mainly in the hypothalamus, a brain area known to be involved in the regulation of food intake. In addition to regulating satiety, leptin increases thermogenesis via sympathetic nervous system activity, 9 and recent animal studies suggest that leptin also participates in the regulation of blood pressure. 10 A single transcription unit of leptin receptor may serve to generate more than one protein. For instance, several isoforms can be derived from a single gene locus by alternative hnRNA splicing, including a long isoform expressed primarily in the hypothalamus and several short isoforms with a much wider tissue distribution.
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Mutations in the gene encoding leptin are reported to cause severe obesity in both animal models, 12 and humans, 13, 14 indicating a direct relationship between the leptin gene and obesity. Although the frequency of such mutations is very low, common polymorphisms of the leptin and LEPR may well contribute to a common form of obesity and, as a consequence, obesity-related diseases. Rosmond et al 15 found an association between the most prevalent LEPR polymorphisms (Lys109Lys and Gln223Gln) and blood pressure in caucasic obese men.
We have analysed the distribution of two LEPR polymorphisms (Gln223Arg and Pro1019Pro) in adolescents in order to investigate the potential role of genetic variation at the LEPR gene in metabolic and haemodynamic traits related to obesity in Mexican adolescents.
Materials and methods
For study we selected 103 adolescents (55 obese and 48 lean) 12-17 years old (34 female and 69 male), with steady body weight for the last 3 months, all of them born in Guanajuato, Mexico. All subjects had normal blood pressure, were nonsmokers, and without thyroid dysfunction, or chronic-degenerative illnesses. None of them had received anorexigenic drugs, beta blockers agents, calcium antagonists or vasodilator drugs.
All subjects and at least one parent were informed about the purpose of the study and gave their informed consent to participate. The protocol of the study was approved by the local ethical committee.
We considered body mass index (BMI) for age X95th percentile to identify obesity and 45th but o85th percentile for nonobese adolescents. 16 Weight and standing height were obtained to calculate BMI. Skinfolds were measured to calculate percent of body fat (%BF) as reported by Slaughter et al, 17 and girth values to obtain waist to hip ratio (WHR). Blood pressure was obtained using a mercury sphygmomanometer with a cuff covering two-thirds of the right arm. After 15 min in rest, two readings were made within a 5-min interval, and the average was registered.
Heart sympathetic activity was evaluated with 60 min electrocardiograph monitoring at rest, from 0800 to 0900 hours using a 3-channel Holter recorder (model GBI-3S, Galix Biomedical Instrumentation Inc.). The tapes were analysed in a Holter Galix software. Spectral analysis was carried out providing the total power (TP) value (from 0.15 to 0.4 Hz), high frequency (HF) band (from 0.15 to 0.4 Hz) and low frequency (LF) band (from 0.05 to 0.15 Hz) to obtain LF/HF ratio as direct measure of heart sympathetic activity. 18 Ectopic beats were identified and excluded from analysis.
Venous blood was obtained after overnight fasting to measure glucose, leptin, and insulin levels. Insulin resistance was estimated by means of the HOMA-IR index with the formula: fasting serum insulin (mU/ml) Â fasting plasma glucose (mmol/l)/22.5.
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Laboratory assays
Plasma glucose was determined by the glucoseoxidase-method. Serum insulin was measured with a solid phase radioimmunoassay (Diagnostic Products Corporation, Los Angeles, CA, USA). The intra-and interassay coefficients of variation were 3.0 and 4.5%, respectively. Serum leptin was measured with a immunoradiometric assay (IRMA) (Diagnostics Systems Laboratories, Inc., Webster, TX, USA). The intra-and interassay coefficients of variation were 3.4 and 6.7% respectively.
Detection of polymorphisms in LEPR gene
Genomic DNA was extracted from whole blood by a standard procedure. 20 Human leukocyte nuclei were precipitated, washed, and lysed in SDS. Proteins were precipitated by the addition of a saturated NaCl solution, and DNA was subsequently precipitated with ethanol and dissolved in a Tris-ethylenediaminetetraacetate solution. For both polymorphisms, 100 ng of genomic DNA were amplified. 
What is known on this topic
What this paper adds
In humans, Gln223Arg polymorphisms of LEPR have been associated with higher blood pressure levels, hyperinsulinaemia, glucose intolerance, and higher BMI. Obese Zucker rats, which have a mutation in the LEPR, do not have increased sympathetic nervous system activity despite their associated obesity and elevated leptin and insulin levels. The association between LEPR polymorphisms and heart sympathetic activity in humans has not been studied
We found that Gln223Arg LEPR polymorphism is associated with variation in heart sympathetic activity in addition to other clinical and anthropometric variables related to obesity in Mexican adolescents fragment length polymorphism (PCR-RFLP) analysis was performed using Msp I for the Gln223Arg polymorphism, and Hinc II for Pro1019Pro polymorphism. 21 PCR consisted of one cycle of denaturation for 45 s at 941C, annealing for 45 s at 551C, and extension for 90 s at 721C, followed by 30 cycles at 941C for 45 s, annealing at 551C for 45 s, extension at 721C for 45 s, and final extension of 10 min at 721C. To ensure there were no partial digestions, a DNA sample from homozygote individual in all digestion procedures as internal control was used, as well as to ensure the enzymatic activity, we used a viral DNA (l DNA) and pBR322 DNA with known restriction sites to each enzyme restriction required. Amplified products were visualized by polyacrylamide gel electrophoresis stained with silver nitrate.
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Statistical analyses
Descriptive statistic is reported as means7s.d. Fitness to the normal distribution was carried out with the K-S test. Differences between obese and nonobese adolescents were tested with the unpaired Student's t-test or the Mann-Whitney U-test when data showed significant departure from normality. Tanner score and gender were analysed by w 2 -test. For analysis, insulin, leptin, HOMA-IR, and the frequency domain measures of HRV were logtransformed considering their significant departure from normality. Allelic and genotype frequencies are presented as percentages and were tested for Hardy-Weinberg equilibrium and compared using the w 2 -test. Analysis of covariance was performed, with gender as covariate for comparisons across Gln223Arg polymorphism and least significant difference as post hoc test. We performed Bonferroni correction for multiple testing. Since insulin levels are a good parameter of metabolic disturbances in obesity, we decided to separate subjects according to the upper quartile in insulin levels (100.4 pmol/l) as follows: p100 or 4100 pmol/l. A P-value of 0.05 or less was considered statistically significant. All data were analysed using the STATISTICS software version 6.0 (Statsoft Inc., Tulsa, OK, USA).
Results
Subject characteristics
A total of 103 adolescents were included in the study (55 obese and 48 nonobese). Anthropometric and clinical variables of obese and nonobese subjects are shown in Table 1 . There was no difference on age and Tanner score. The group of obese adolescents showed higher LF/HF index, blood pressure, glucose, insulin, and leptin levels. In contrast, TP was lower in obese adolescents.
Gene frequencies
Allele and genotype frequencies of Gln223Arg and Pro1019Pro polymorphisms, are shown in Table 2 . Genotype frequencies for the two polymorphisms were found to be in Hardy-Weinberg equilibrium (P ¼ 0.90 to Gln223Arg, and P ¼ 0.21 to Pro1019Pro polymorphism, respectively). No significant difference was found in the genotype frequencies for Gln223Arg polymorphism between (16) obese and nonobese subjects. A retrospective power calculation of 0.82 was obtained with these parameters.
LEPR polymorphisms according to insulin levels
Although the original genetic hypothesis was to test for association of LEPR polymorphisms and obesity, we subdivided the group of adolescents according to insulin levels. There was a higher prevalence of the Gln223 allele among subjects with insulin levels 4100 pmol/l (0.73 vs 0.56; P ¼ 0.04). The allele and genotype frequencies for Pro1019Pro polymorphism were not different between the obese and nonobese groups, or between the groups with different insulin levels. The group of adolescents with insulin levels 4100 pmol/l had higher BMI, insulin resistance index, leptin levels, blood pressure, and heart sympathetic activity (Table 3) . When we analysed the subjects according to Gln223Arg polymorphism, those individuals with the Gln allele (Gln/Gln, and Gln/Arg) had higher %BF, leptin levels, and LF/HF index (Table 4) .
Discussion
In this study, we confirmed that obese adolescents have higher heart sympathetic activity, blood pressure, insulin, and leptin levels than nonobese subjects. Some of these parameters integrate the insulin resistance syndrome, and have been related to higher risk of hypertension and cardiovascular disease in the adulthood. 5, 24 The autonomic imbalance found in obese adolescents was characterized by decrease in total power, and increase in LF/HF index express heart sympathetic overactivity. This feature has been associated with heart failure, 25 and is a mechanism for generation of ventricular arrhythmias and sudden death. 26 Moreover, adrenergic activation in obesity appears to play a pathogenic role of the high blood pressure state. 27, 28 Leptinaemia relates to the amount of body fat and it was higher in obese adolescents. In rats, infusions of leptin, increased sympathetic activity in the kidneys, adrenals, and brown adipose tissue. At rates that increased plasma concentrations to about 94 ng/ ml, leptin raised mean arterial pressure and heart rate despite marked reductions in food intake. 9, 29 Gln223Arg polymorphism is within the region encoding the extracellular domain of the leptin receptor. Therefore, the amino-acid change affects all forms of the receptor and may change functional characteristics of it. According to LEPR polymorphisms, those subjects Gln223 carriers had, in comparison with Arg homozygotes, higher LF/HF index, and other traits related to obesity like %BF and serum leptin levels despite no significant difference in BMI. One of the effects of leptin administration to animals is the activation of sympathetic nervous system (SNS), 30 and in a previous study, we reported that plasma leptin concentrations were positively correlated with heart sympathetic activity in obese subjects. 31 Thus, an impaired leptin signalling due to the Gln223 polymorphism in LEPR may affect the 32 and why not all obese subjects have an hyperkinetic state characterized by sympathetic overactivity and hypertension. Obese Zucker rats, which have a mutation in the LEPR, do not have increased sympathetic nervous system activity despite their associated obesity and elevated leptin and insulin levels, which would make them particularly prone to blood pressure elevation. 33 In Swedish subjects, Rosmond et al 15 found that Arg223 homozygotes had, in comparison with Gln223 homozygotes, lower systolic and diastolic blood pressure. Wauters et al 34 found that postmenopausal women, homozygotes for Gln223 allele compared with Arg carriers, had higher fasting insulin as well as 2 h insulin during an oral glucose tolerance test. In another study, although Gln223Arg was not associated with adiposity in Pima Indians, subjects homozygous for the Arg223-encoding allele had lower 24 h energy expediture compared with Gln/Gln and Gln/Arg genotypes. 35 However, Silver et al 36 did not find association between the Gln223Arg polymorphism in the human leptin receptor with traits related to obesity, and Quinton et al 37 in Caucasian postmenopausal women reported that subjects carrying the Arg223 allele had significantly higher BMI, circulating levels of leptin, and fat mass.
In our study, more than half subjects with insulin levels p100 pmol/l were Gln223 carriers. Leptin receptors are present on pancreatic b-cells, which could offer one mechanism by which leptin could modulate glucose-induced insulin secretion. 38 Potential limitations of this study include its moderate size. We did not explore associations between body composition variables and polymorphisms separately in subgroups divided by gender because of the expected small size of the subgroups; however, we adjusted for gender in the statistical analysis.
In conclusion, our results support the hypothesis that Gln223Arg LEPR polymorphism is associated with variation in heart sympathetic activity, leptin levels and body fat percentage in adolescent subjects. However, the role of Gln223Arg polymorphism do not seem to have a major impact on BMI in this population. The present data also do not allow for a determination of whether the observed associations are due to direct functional consequences of the Gln223Arg polymorphism. Since phenotypic expression of a given gene variant may be dependent on genetic (ethnic) background, additional studies to clarify the role of the Gln223Arg polymorphism on leptin action in human metabolism and sympathetic activity are needed.
